Displaying results 1 - 2 of 2
Clear search
Inivata to be acquired by NeoGenomics
Research Triangle Park, NC, USA and Cambridge, UK… Inivata, a leader in liquid biopsy, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research services, has agreed to acquire Inivata.
Inivata raises $35 million in second close of Series C financing
Inivata, a leader in liquid biopsy, announced that it has raised $35 million (£25.7 million) in a second close of a Series C financing round.